China SXT Pharmaceuticals, Inc. Liabilities, Current
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-07-01
- 2026-03-31: Liabilities, Current $4.35M.
- 2025-09-30: Liabilities, Current $5.96M.
- 2025-03-31: Liabilities, Current $6.01M.
- 2024-09-30: Liabilities, Current $15.66M.
| Period end | Liabilities, Current |
|---|---|
| 2026-03-31 | $4.35M 20-F · filed 2026-07-01 |
| 2025-09-30 | $5.96M 6-K · filed 2025-12-31 |
| 2025-03-31 | $6.01M 20-F · filed 2026-07-01 |
| 2024-09-30 | $15.66M 6-K · filed 2025-03-28 |
| 2024-03-31 | $8.90M 20-F · filed 2025-07-31 |
| 2023-09-30 | $9.20M 6-K · filed 2024-04-05 |
| 2023-03-31 | $14.50M 20-F · filed 2024-08-13 |
| 2022-09-30 | $7.29M 6-K · filed 2023-02-24 |
| 2022-03-31 | $17.12M 20-F · filed 2023-07-31 |
| 2021-09-30 | $8.88M 6-K · filed 2022-01-14 |
| 2021-03-31 | $18.58M 20-F/A · filed 2023-05-19 |
| 2020-09-30 | $5.51M 6-K · filed 2021-01-28 |
| 2020-03-31 | $12.26M 20-F · filed 2021-08-13 |
| 2019-09-30 | $10.76M 6-K/A · filed 2020-05-22 |
| 2019-03-31 | $6.32M 20-F · filed 2020-07-31 |
| 2018-03-31 | $4.37M 20-F · filed 2019-08-15 |